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Objective: We identify complexities encountered, including unanticipated crossover between trial arms
and inadequate “standard of care” violence services, during a cluster randomized trial (CRT) of a
community-level intimate partner violence (IPV) and HIV prevention intervention in Uganda. Method:
Concepts in public health ethics—beneficence, social value of research, fairness, standard of care, and
researcher responsibilities for posttrial benefits—are used to critically reflect on lessons learned and
guide discussion on practical and ethical challenges of violence intervention CRTs. Results: Existing
ethical guidelines provide incomplete guidance for responding to unexpected crossover in CRTs pro-
viding IPV services. We struggled to balance duty of care with upholding trial integrity, and identifying
and providing appropriate standard of care. While we ultimately offered short-term IPV services to
controls, we faced additional challenges related to sustaining services beyond the “short-term” and
posttrial. Conclusion: Studies evaluating community-level violence interventions, including those com-
bined with HIV reduction strategies, are limited yet critical for developing evidence-based approaches for
effectively preventing IPV. Although CRTs are a promising design, further guidance is needed to
implement trials that avoid introducing tensions between validity of findings, researchers’ responsibilities
to protect participants, and equitable distribution of CRT benefits.
Keywords: intimate partner violence, cluster randomized trial, research ethics, HIV, Rakai, Uganda
Intimate partner violence (IPV), one of the most common forms
of violence against women (VAW), is defined as “any behavior
within an intimate relationship that causes physical, psychological,
or sexual harm to those in the relationship” (Krug, Dahlberg,
Mercy, Zwi, & Lozano, 2002). A 2010 meta-analysis using data
from 81 countries found 30.0% of women aged 15 years and above
have experienced physical and/or sexual IPV in their lifetime. The
settings with the highest IPV prevalence were in sub-Saharan
Africa (Devries et al., 2013), the region most affected by HIV/
AIDS (UNAIDS/World Health Organization, 2013) and where
significant associations have been found between IPV and HIV
infection (Kouyoumdjian et al., 2013a; UNAIDS/World Health
Organization, 2013). It is now widely accepted that IPV is both a
precursor to and sequelae of HIV infection (Campbell et al., 2008;
Maman, Campbell, Sweat, & Gielen, 2000; UNAIDS/World
Health Organization, 2013). In response, a growing number of
combination IPV and HIV prevention interventions has been im-
plemented and systematically evaluated through randomized trials,
primarily in sub-Saharan Africa. The purpose of this article is to
discuss some of the practical, ethical, and safety challenges intro-
duced by randomized violence intervention trials. We examine
field-based experiences of and lessons learned by the researchers
who conducted and evaluated the Safe Homes And Respect for
Everyone (SHARE) Project in rural Uganda between 2005 and
2009.
A Call for Rigorous Evaluation of IPV Interventions
Given the high global prevalence of IPV and the negative health
and social consequences associated with its occurrence (Campbell,
2002; Campbell & Soeken, 1999; Ellsberg et al., 2008), a range of
different prevention approaches has been designed and imple-
mented in multiple countries and development contexts. Some of
these interventions have combined strategies to address the bidi-
rectional relationship between IPV and HIV infection, particularly
in sub-Saharan Africa (Anderson, Campbell, & Farley, 2013).
Nonetheless, research to evaluate the feasibility and effectiveness
of these programmatic efforts is limited, particularly in low and
middle income countries. As a result, urgent investment has been
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called for to increase the evidence base on effective partner vio-
lence prevention interventions (Ellsberg et al., 2014; Heise, 2011),
including approaches that address gender inequality and violence
as part of a combination HIV response (Watts & Seeley, 2014).
Evaluating the impact of primary prevention approaches con-
ducted in low and middle income countries has emerged as a high
research priority (Ellsberg et al., 2014; Heise, 2011). In areas of
high IPV and HIV prevalence, such as sub-Saharan Africa,
community-level work has been identified as an important strategy
for sustained change at the population level (Michau, Horn, Bank,
Dutt, & Zimmerman, 2014). In order to inform policy and support
effective and efficient approaches to violence prevention, it is
necessary to evaluate the impact of primary prevention interven-
tions in a scientifically valid and rigorous way (Ellsberg et al.,
2014; Heise, 2011).
Randomized controlled trials (RCT) have come to be regarded
as the “gold standard” for evaluating the effectiveness of public
health interventions and the strengths of this study design are
widely recognized. RCTs allow for simultaneous comparison of
intervention and control groups. Further, if randomization is done
correctly, it can enhance investigators’ ability to ensure partici-
pants in both arms are comparable on all characteristics apart from
the intervention conditions under study (Hayes & Moulton, 2009).
For some health interventions, it is more appropriate to randomize
groups of individuals (vs. individual participants) to the different
treatment arms. This design is known as a cluster randomized trial
(CRT). CRTs are ideal when the intervention will be applied to
entire communities (or other groupings of individuals), such as
community mobilization activities recommended for IPV preven-
tion (Michau et al., 2014). Other reasons for the CRT design are
when contamination between individuals in the same community
is likely if they are randomized to different treatment arms; and
when a main research goal is to measure population-level effects
of the intervention (Hayes & Moulton, 2009).
Ethical Challenges of Randomized IPV
Intervention Trials
International guidelines have been established for the ethical
conduct of biomedical research involving human subjects (Council
for International Organizations of Medical Sciences, 2002; World
Medical Association, 2013). However, despite the widespread use
of internationally and locally accepted ethical guidelines, the sub-
ject of VAW and the method of CRTs each have practical aspects
that are not easily resolved with these standard guidelines. For
instance, research focused on VAW can raise questions on how to
maintain participant confidentiality when conducting research in
settings with mandatory reporting laws, and how to mitigate un-
derreporting of abuse so as to prevent biased information about the
magnitude of the problem (Ellsberg & Heise, 2002; Wagman,
Francisco, Glass, Sharps, & Campbell, 2008; World Health Orga-
nization, 2001). CRTs are more complex than the traditional RCT
design and introduce ambiguity with respect to defining the re-
search subject, how and from whom to obtain consent, and how to
balance risks and benefits across both individuals and groups that
are involved in CRTs (Hayes & Moulton, 2009; Weijer et al.,
2012). In response to these and many other issues, two sets of
targeted guidelines have been developed: The World Health Or-
ganization developed recommendations for conducting safe and
ethical population-based survey research on domestic VAW
(World Health Organization, 2001). They were written for re-
searchers, donors, research ethics committees (RECs), and others
initiating or reviewing research on VAW. Eight recommendations
were put forth to address safety of respondents and the research
team; ensuring domestic violence studies are methodologically
sound; protection of confidentiality; careful selection and training
of researchers; reducing participant distress; training fieldworkers
to make referrals; dissemination of findings; and only including
violence questions in surveys designed for other purposes when
ethical and methodological requirements can be met. More re-
cently, the Ottawa Statement on the Ethical Design and Conduct of
Cluster Randomized Trials set out 15 recommendations for the
ethical design, conduct, and review of CRTs. The 15 recommen-
dations were written to provide guidance to researchers and RECs
on seven ethical issues: justification of a cluster randomized de-
sign, the need for REC review, the identification of research
participants, obtaining informed consent, the role of gatekeepers in
protecting group interests, the assessment of benefits and harms,
and the protection of vulnerable participants (Weijer et al., 2012).
Although these additional violence and CRT guidelines were a
step forward, randomized trials to evaluate IPV prevention inter-
ventions—including those aimed at both individuals and groups of
individuals—face practical challenges in responding to common
research ethics and safety considerations. For example, what
should be offered to control communities in a trial investigating
the optimal delivery approach of an intervention likely to be
effective in a setting with no standard of care? How should
researchers balance obligations to provide care for at-risk individ-
uals while upholding the validity of a randomized cluster design?
What responsibilities do researchers have for the sustainability of
effective, community-level intervention approaches? Although
some of these issues have been addressed in recent recommenda-
tions for VAW intervention research (Hartmann & Krishnan,
2014), practical experiences and lessons learned are essential for
moving the field toward the development of refined guidelines for
the safe and ethical conduct of randomized IPV intervention trials.
This paper describes the practical and ethical challenges re-
searchers experienced when unanticipated crossover occurred dur-
ing a CRT to evaluate a community-based, primary IPV prevention
intervention (the SHARE Project) that was integrated into an
existing HIV organization in rural Uganda (the Rakai Health
Sciences Program). We briefly describe the IPV intervention, and
the unexpected crossover that occurred during the intervention
trial’s implementation, discuss the practical and ethical challenges
that followed, summarize lessons learned, and raise questions for
further consideration.
The SHARE Intervention Setting
Rakai District, Uganda
The SHARE intervention was conducted between 2005 and
2009 in the southwest Ugandan district of Rakai, where the first
HIV/AIDS cases were identified in the country in 1982 (Serwadda
et al., 1985). The district has a generalized HIV epidemic and HIV
prevalence (12%) remains among the highest in the country, ex-
ceeding the national average of 7.2% (UNAIDS/World Health
Organization, 2013). IPV against women is highly prevalent in
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443ETHICS OF RANDOMIZED VIOLENCE INTERVENTION TRIALS
Rakai. Half (49.8%) of all women (aged 15–49 years) report
having experienced some form of IPV (emotional, physical, and/or
sexual) in their lifetime; approximately one third (29.0%) report
any IPV in the past year. Two thirds (66.0%) of abused women in
Rakai reported that they experienced more than one form of
violence concurrently (Kouyoumdjian et al., 2013b). Partner vio-
lence’s role in increasing women’s risk for HIV infection has been
evidenced in Rakai. Research found women who had ever expe-
rienced IPV were significantly more likely to acquire HIV com-
pared with women who had never experienced abuse (aIRR 
1.55, 95% CI: 1.25–1.94; Kouyoumdjian et al., 2013a).
Rakai Health Sciences Program and Rakai
Community Cohort Study
The SHARE IPV prevention intervention and evaluation trial
were conducted by the Rakai Health Sciences Program (RHSP),
which has conducted research on and provided services for HIV/
AIDS and reproductive health in rural Uganda since 1988. Since
1994, RHSP has followed an open, community-based cohort of
approximately 12,000 participants aged 15–49 years who reside in
50 communities that are aggregated into 11 study clusters. This
longitudinal study is called the Rakai Community Cohort Study
(RCCS), and it has been described in detail elsewhere (Wawer et
al., 1998; Wawer et al., 1999). RCCS is the main study conducted
by RHSP but serves as an offshoot to many smaller quantitative
and qualitative investigations. All RHSP study participants are
offered general health services including routine medical care,
family planning, health education, and community mobilization.
They are also provided standard of care HIV-related services
including voluntary HIV testing and counseling (HCT), HIV pre-
vention education, condom distribution, prevention of mother-to-
child HIV transmission, provision of antiretroviral therapy (ART),
and pre-ART care and provision of a basic HIV care package.
The SHARE Violence Prevention Intervention Trial
The SHARE Intervention
In June 2005, RHSP initiated the multicomponent SHARE IPV
prevention intervention, which has been described previously
(Wagman et al., 2012). In this paper, we focus on ethical issues
related to the primary component of the SHARE intervention,
which was a community mobilization approach that aimed to
reduce physical and sexual IPV by changing social norms that
support violence. SHARE was uniquely positioned to also address
the links between IPV and HIV infection since the intervention
was integrated into RHSP’s existing HIV programming (Wagman,
King et al., 2015). As such, SHARE also implemented an HCT-
based screening and brief intervention (SBI) program. The goals of
the SBI were to increase rates of nonviolent HIV disclosure among
women testing HIV positive for the first time and improve wom-
en’s capacity to negotiate consensual and HIV risk-free sex (e.g.,
by using condoms) with violent spouses/partners (Wagman, Gray,
et al., 2015; Wagman, King, et al., 2015).
SHARE’s community mobilization approach was an adaption of
Raising Voices’ Resource Guide for preventing domestic violence,
which was specifically developed for use in East and Southern
Africa (Michau & Naker, 2003). Its methods were previously
found to reduce partner-level violence and attitudes condoning its
acceptance in urban Uganda (Raising Voices and Center for Do-
mestic Violence Prevention, 2003). Its approach is based on the
Transtheoretical Model of behavior change, the central construct
of which is the Stages of Change Theory (Prochaska & Di-
Clemente, 1983; Prochaska & Velicer, 1997). This theoretical
approach was chosen by Raising Voices based on their extensive
practical experience, during which they found it to be appropriate
and acceptable in many different cultures and countries, including
Uganda (Michau & Naker, 2003). The Resource Guide has been
successfully implemented in 22 African countries including 8 in
East and Southern Africa (Ruff, 2005).
As recommended (Michau & Naker, 2003), we scaled up the
Stages of Change Theory for delivery at the community level
because societal transformation requires moving beyond individ-
uals, and it was posited that communities, like individuals, go
through multiple stages of change before any given value system
or final behavior change is fully adopted. Following the suggested
process, we organized SHARE in five consecutive phases for
affecting social change. These five phases, based on the stages of
individual behavior change but amplified to work at a broader
community level, were spread out over the life of the intervention
(ending in December 2009). SHARE also adapted methods from
Stepping Stones to address gender roles and promote equitable
relationships among adolescents. We chose the Stepping Stones
approach because it was originally developed for use in Uganda
(and deemed culturally appropriate), has been used in more than 40
countries, including many East and Southern African countries
(Welbourn, 1995) and found to reduce male perpetration of IPV in
South Africa (Jewkes et al., 2008).
The SHARE Evaluation Trial
SHARE was conducted as part of an intervention trial to assess
whether it would reduce IPV and HIV incidence in individuals
enrolled in RCCS. We chose a cluster randomized design, with
four intervention group and seven control group clusters, because
SHARE was primarily delivered to entire communities, a main
goal was to measure population-level effects of the intervention,
and we expected some contamination between arms (Hayes &
Moulton, 2009).
The SHARE intervention study built on a prior CRT (1999–
2003) conducted to assess the impact of enhanced family planning
outreach in Rakai. The family planning CRT randomized five
RCCS clusters to the control arm and six to the intervention arm
(Lutalo et al., 2010). We built on this design and randomly chose
(via a computer-generated randomization program) four SHARE
intervention clusters from the original six family planning inter-
vention clusters. More intervention clusters were not chosen for
the SHARE trial due to funding limitations. The seven control
clusters in our study consisted of the five control clusters from the
original family planning CRT plus the remaining two family
planning intervention clusters (Wagman, Gray, et al., 2015). Fig-
ure 1 shows a map of the Rakai district and highlights the location
of the four intervention and seven control clusters for the SHARE
trial.
Participants in the four intervention clusters were provided
RHSP’s standard of care health and HIV services, and were also
exposed to SHARE’s community-level mobilization intervention
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as well as the HCT-based SBI. The seven control group clusters
received only standard of care health and HIV services from
RHSP. The impact of SHARE was evaluated by analyzing RCCS
data from three time points. A baseline survey (February 2006–
June 2006) was conducted prior to the initiation of SHARE inter-
vention activities. Two follow-up surveys were conducted between
August 2006 and April 2008, and June 2008 and December 2009.
The primary endpoints for our study were self-reported experience
(women) and perpetration (men) of past year IPV (emotional,
physical, and sexual) and laboratory-based diagnosis of HIV inci-
dence in the study population (Wagman, Gray, et al., 2015). Thus,
the SHARE trial included an evaluation both of the effectiveness
of the community-level mobilization to reduce IPV in the Rakai
society, as well as the effectiveness of the implementation ap-
proach of integrating IPV prevention within the existing HIV
service delivery infrastructure of RHSP.
Practical and Ethical Challenges
SHARE’s community mobilization approach used five main
IPV prevention strategies: advocacy, capacity building, commu-
nity activism, learning materials, and special events. The advocacy
and capacity building activities were primarily organized with
targeted groups of participants in designated, controlled locations,
and thus had minimal public exposure. In contrast, most of the
activism, learning materials and special events were designed for
community-based implementation and to maximize public expo-
sure, and were thus conducted in open spaces. Table 1 outlines the
five SHARE strategies, lists main activities conducted under each,
and indicates the level of public exposure per strategy.
Unanticipated Crossover of Participants Between
Trial Arms
Crossover during community events. Given the nature of
and activities involved in the SHARE strategies, all individuals
present in the intervention arm clusters were offered full exposure
to the community-level forms of “intervention” (e.g., community
activism, learning materials, and special events). As demonstrated
in Figure 1, some of the RHSP/SHARE trial’s intervention and
control regions were adjacent or close to one another. Movement
between different communities and regions is not uncommon.
Concerns emerged when SHARE staff members realized that some
intervention activities were attended by control region individuals
who were present in intervention areas (to visit friends/relatives,
go shopping, passing through, etc.) at the time of the event.
As part of the community activism strategy, SHARE appointed
40 community volunteers (CVs)—10 per each SHARE cluster—to
help, on an ongoing basis, facilitate project activities and events
(Wagman et al., 2012). Because CVs were resident members of
their cluster, they were able to recognize familiar and unfamiliar
intervention participants. Crossover for community events was
most commonly reported by CVs in the Katana (#6) and Buyamba
(#7) intervention clusters, which were adjacent to the Kyotera (#1)
and Lwanda (#8) control clusters, respectively. Such “unintended
exposure” was concerning to SHARE staff who realized that
unanticipated behavior change might occur among control partic-
ipants and ultimately bias study results. While we expected some
contamination between treatment arms and planned to employ an
“intention to treat” statistical analysis (anticipating some unavoid-
able “crossover effects” in our findings), the unintended exposure
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Figure 1. Map of SHARE intervention and control clusters in Rakai District, Uganda.
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445ETHICS OF RANDOMIZED VIOLENCE INTERVENTION TRIALS
contributed to a more difficult challenge that we had not planned
for, namely responding to requests for services for the additional
crossover population.
Unanticipated crossover related to requests for service and
individual support. The crossover led to additional requests
for services and individual support from abused women resid-
ing in control clusters. Some women from control areas heard
about the SHARE Project (through diffusion of information,
including word of mouth from SHARE volunteers), sought out
intervention staff and disclosed personal experiences of IPV,
and/or requested access or referral to focused IPV-related sup-
port, care, and health services. As mentioned, we trained RH-
SP’s resident HCT counselors in SHARE clusters (one per
cluster) to screen for IPV and help women develop safe HIV
disclosure plans, offer facilitated disclosure of HIV results, and
practice risk reduction strategies for avoiding violence in inti-
mate relationships (Wagman, Gray, et al., 2015). We also
appointed and trained 12 community counseling aides, three per
intervention cluster, to offer basic support to community mem-
bers experiencing violence and liaise with and refer to RHSP’s
professional counselors (Wagman et al., 2012). Although each
of the control clusters also had a resident HIV counselor from
RHSP, focused IPV counseling and support was not available
from these providers. Further, community counseling aides
were not appointed in control clusters. Thus, some violence
victims in control areas heard indirectly about the availability of
specialized IPV-related services in neighboring regions and
traveled to seek personal assistance for their own situational
needs.
The ethical issues surrounding our response to unantici-
pated crossover. This unanticipated crossover created a tension
between the integrity of the trial and maintaining appropriate
comparison groups, and a duty of care to protect participants from
harms and ensure that any risks of harm are justified by the
benefits of the research. Our goal of evaluating a violence inter-
vention that was integrated into an existing HIV program in Rakai
was rooted in the social value of the research, and our aim to find
effective strategies to reduce behaviors that increased risk for IPV
in the population. Randomizing some clusters to receive no inter-
vention is ethically justified when it can be argued that there is
equipoise, meaning genuine uncertainty regarding the relative ef-
ficacy of one treatment condition over another (Hayes & Moulton,
2009). In studies that address specific delivery methods, such as
the integrated IPV/HIV delivery approach used in SHARE, it has
been argued that the concept of equipoise should apply to the
uncertainty of the delivery approach and how an intervention
ought to be delivered, rather than the uncertainty surrounding the
effectiveness of the intervention itself (Hyder, Pratt, Ali, Kass, &
Sewankambo, 2014; Kukla, 2007). However, in this case, there
were different levels of uncertainty associated with the effective-
ness of the IPV intervention and the integrated approach within the
HIV service infrastructure. Although SHARE did adapt “proven
successful” IPV prevention strategies from Raising Voices (Mi-
chau & Naker, 2003; Raising Voices and Center for Domestic
Table 1
Level of Community Exposure, Activities, and Target Population of Each SHARE IPV Prevention Strategy
Strategy Level of community exposure Activities conducted Target population
Advocacy High exposure among target group
only
• Workplace dialogues Local and religious leaders, local
organizations and government, teachers,
health care workers.
• Targeted local group seminars
Low exposure in general
community
• Focused dialogues with opinion and local
leaders
• Professional network for service providers
Capacity building High exposure among target group
only
• Staff development workshops Police, probation and social welfare
officers, health care providers, teachers,
local and religious leaders, SHARE staff
and volunteers, and RHSP counselors
and staff.
• Training of resource persons and volunteers
Low exposure in general
community
• Seminars
• Targeted workshops and trainings on IPV,
human and women’s rights.
Community activism High exposure in general
community (target population
 community)
• Collaborative work with community
volunteers
Women and men, youth and children
within the community.
• Public booklet clubs
• IPV prevention action groups
• Door-to-door awareness activities
Learning materials High exposure in general
community (target population
 community)
Development, adaptation, and distribution of:
• Booklets and brochures General public, community members, local
organizations, health care providers, and
social service officers.
• Posters
• Story cards
• Other educational materials
Special events High exposure in general
community (target population
 community)
• Local fairs Community members, leaders, the general
public, and local institutions.• Public marches
• Public campaigns
• Open poster exhibitions
• Community drama shows
• Outdoor films and music events
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Violence Prevention, 2003) and Stepping Stones (Jewkes et al.,
2008; Welbourn, 1995), there remained some level of uncertainty
about its effectiveness in the Rakai context, although it may have
been presumed more likely to be effective than not. There was
much greater uncertainty around the effectiveness of the approach
of integrating IPV within existing HIV services infrastructure, as
no prior IPV evaluation was shown effective in lowering HIV
incidence (Wagman, Gray, et al., 2015). Thus, it could be justifi-
able to randomize clusters to the SHARE IPV intervention given
the uncertainty regarding the outcomes of the integrated delivery
approach, yet at the same time, ethically objectionable to deny an
individual from the control group access to the IPV intervention
shown to be effective in other settings.
We were also confronted with a limitation in our ability to
minimize harms to participants given our limited resources. Al-
though SHARE had the capacity to do public prevention activities
for as many individuals as wished to participate, specialized ser-
vices, such as counseling, were only set up to serve the needs of
those in the intervention regions. No such systems had been put in
place to offer specialized IPV-related services in control regions.
Extending these services to control participants who crossed over
to intervention regions would have had negative consequences for
the providers, who lacked resources to serve so many people, as
well as to the intervention participants, who would not receive
adequate attention. Thus, even if there were no concerns for the
integrity of the trial, and we sought to provide services to all
women identified with IPV risk, resource constraints presented
obstacles to referring control region residents to the services pro-
vided in the intervention arm.
This pushed us to consider our responsibilities more carefully.
How far did our responsibility as care-givers to “prevent or remove
harm” extend? What did we, as researchers, owe to those allocated
to the control arm of the trial? We recognized that withholding
support services (e.g., psychosocial counseling) and referral (e.g.,
links to social welfare) might be life-threatening, fail to prevent the
preventable (future violence) or cause serious physical, sexual, or
emotional harm. At the same time, we recognized the importance
of generating evidence for these kinds of interventions for future
policy impact, which may have much broader social benefit, and
were aware that the standard of care in Uganda did not offer IPV
services in any form. We thus had to reconcile a duty of care to
participants with our responsibilities as researchers for the social
value of the investigation.
To establish our course of action, we consulted several individ-
uals and groups with capacity to make decisions to effectively
balance benefits and harms to the research population in Rakai. We
discussed all issues with RHSP senior investigators, and sought
feedback from the local institutional review board. We also con-
vened a meeting with members of RHSP’s Community Advisory
Board, which provides local knowledge input on new and ongoing
studies, liaises with communities, and is involved with the review
and approval of all RHSP studies and projects.
Together, we identified three options. First, we could allow
control region individuals to freely participate in SHARE violence
prevention and treatment activities and note this as a limitation in
our research. Second, we could allow control region individuals to
participate in SHARE violence prevention activities but not access
IPV-related services. Third, we could exclude control area indi-
viduals from all SHARE activities and instead refer those seeking
violence prevention services elsewhere in Rakai.
Ultimately, we felt our duty to protect women at risk of violence
from harm, irrespective of where they resided, outweighed con-
cerns for the integrity of the trial design. We made a preliminary
decision to allow control region individuals to participate in
SHARE violence prevention activities (since it was too difficult to
limit exposure) but exclude them from accessing specific IPV-
related services (such as psychosocial support, risk reduction coun-
seling) offered through SHARE and instead refer them to available
services in their respective communities. This, however, led to a
new challenge, namely the lack of adequate, existing “standard of
care” IPV-related services.
When There Is No Standard of IPV Care
As is common in many resource poor settings, violence-related
support services were basically nonexistent in the SHARE and
non-SHARE regions of Rakai. As part of the intervention, we did
establish a prevention and referral network among local agencies
and professionals in Rakai. Network members included Rakai
District Police, probation and social welfare officers, and govern-
ment representatives from the Offices of Health, Education, and
Gender. Police and social welfare officers were offered a one-time
training on IPV and all members were invited to participate in
biannual information sessions, and a system of referral was estab-
lished to help women seek legal and civil assistance and counsel-
ing where possible (Wagman et al., 2012). Despite these activities,
however, network members were not specifically attached to any
of the RCCS clusters, and most were not trained to ask about or
offer meaningful services related to cases of IPV. As a result,
referring women from control cluster to violence-related services
in their own communities may not have been successful in mini-
mizing harms.
The ethical issues surrounding inadequate standard of care
and our course of action. Concerns about appropriate standard
of care provided to RCT and CRT participants in settings where
local health services may not be adequate are common (Hayes &
Moulton, 2009). In the SHARE example, we followed the WHO’s
guidelines for ethical and safe research on domestic violence
(World Health Organization, 2001) by creating short-term sup-
port mechanisms for responding to cases of violence that we did
not have the capacity to serve immediately via the SHARE
Project. SHARE staff members were trained to screen individ-
uals who disclosed violence and assess the severity of their
situation and potential for danger. All violence victims were
offered immediate support in the form of private and confiden-
tial (short-session) counseling and a discussion about risk re-
duction techniques. All women were also provided contact
information (verbally, so as to prevent a paper trail that could
be discovered by an abuser) about the SHARE Project and how
to contact us for further assistance in the case of an emergency.
All women were also triaged. Those experiencing less severe
and threatening forms of abuse were referred to a welfare
officer, as well as a RHSP counselor in her own community for
monitoring and follow-up. Although these individuals (welfare
officers and counselors) had not been working as closely with
SHARE as those in the intervention regions, they had connec-
tions with the overarching RHSP/SHARE infrastructure and
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could access additional support if needed. Further, a SHARE
staff member contacted each of these individuals to let them
know they should expect the new client and to follow up on
each case. Women who disclosed more severe and urgent forms
of abuse were immediately referred to a SHARE-trained HCT
counselor for follow-up and support either with the woman
individually or together with her abusive partner (when appro-
priate and safe). With the abused woman’s consent, she was
also connected with one of the SHARE CVs for ongoing sup-
port, and she was referred to a social welfare officer in the
SHARE region as well as her own. All cases of severe abuse
were followed up on regularly by SHARE staff, CVs, and
community counselors.
Discussion and Lessons Learned
Our practical and ethical experiences conducting the SHARE
study via an existing cluster randomized trial offer several infor-
mative lessons for future randomized IPV intervention evaluations,
particularly in resource-poor settings. We discuss three lessons
below.
Lesson 1: There Is Ongoing Need to Formally
Evaluate Interventions That Address Multiple
and Overlapping Vulnerabilities of Individuals
Experiencing IPV and At Risk for or Living
with HIV
When we began this trial, it was only the third combination
IPV/HIV prevention intervention to be evaluated via CRT. Two
prior trials had been conducted in South Africa (Jewkes et al.,
2008; Pronyk et al., 2006), and neither had shown effective
outcomes for both IPV and HIV. The dearth of existing litera-
ture on combined IPV/HIV prevention interventions represents
a need for further efforts to identify the most effective ways to
address overlapping risks. This is particularly important in low
resource settings where combined approaches may be a partic-
ularly efficient use of limited resources, and in settings like
sub-Saharan Africa where resources are usually more readily
available for HIV than IPV research and service provision.
Lesson 2: Cluster-Randomized Trials Are a
Promising Approach for Intervention Evaluation but
Introduce Numerous Challenges with Practical and
Ethical Implications (Hayes & Moulton, 2009;
Weijer et al., 2012)
The CRT design contributed to two larger considerations for
violence intervention research: (1) What did we owe to control
communities?, and (2) What were our responsibilities for sustain-
ing benefits after the trial?
What should be offered to control communities? CRTs
investigating the effectiveness of IPV interventions or combined
approaches, such as HIV/IPV reduction efforts, raise complex
issues about what ought to be offered to control communities.
Despite that control community participants in the SHARE study
received general health services and standard of care HIV-related
services, they were not exposed to the multicomponent IPV pre-
vention activities. Cluster selection in the SHARE trial was done
by building on a prior family planning outreach CRT in order to
take advantage of the existing infrastructure for community health
workers (Wagman, Gray, et al., 2015), yet this approach resulted
in having some “control” and “intervention” communities in geo-
graphically adjacent regions and contributed to the unanticipated
crossover.
Recent ethical and safety recommendations for intervention
research on VAW suggest “the availability of services to compar-
ison arm participants should maintain an ethically sound standard
of care” (Hartmann & Krishnan, 2014). The Ottawa Statement on
the Ethical Design of Cluster Randomized Trials states that control
communities must not be deprived of effective care or programs to
which they would have access, were there no trial (Weijer et al.,
2012). Thus, although our design was justified given that control
communities would not otherwise have access to violence related
services, the intervention nevertheless set up an inequity in access
to an intervention that seemed likely to be effective.
Hartmann and Krishnan (2014) encourage violence intervention
researchers to consider alternative randomized design approaches,
such as stepped wedge and wait list designs, after the efficacy or
effectiveness evaluation stage. The stepped wedge design seems
particularly appropriate given its approach of involving random
and sequential crossover of clusters from control to intervention.
This design is increasingly employed for evaluation of service
delivery interventions because it allows participants in all clusters
to be exposed eventually, resulting in a more justifiable distribu-
tion of benefits than traditional randomized designs (Hemming,
Haines, Chilton, Girling, & Lilford, 2015). However, step-wedge
designs are not appropriate for all contexts. In areas with small or
homogenous clusters, the design may not be scientifically valid
(Hemming et al., 2015). Although RCCS clusters were large, they
were relatively homogenous (Todd et al., 2003), so this would not
have been an ideal design for the SHARE trial.
Other researchers have assigned intervention clusters en bloc in
order to minimize potential crossover and the ethical tensions it
raises (Bandewar & John, 2011). Although this approach may have
limited crossover and thus the extent to which service providers
experienced distress about how to respond to requests for services,
it would not have addressed the underlying ethical concern that
women in control clusters, regardless of location, lacked access to
needed services that RHSP could potentially provide. Thus, addi-
tional guidance may be needed to assist researchers in providing an
equitable distribution of benefits while maintaining a valid ap-
proach that protects the scientific integrity of CRT results. Further,
while we followed WHO guidelines and set up short-term response
mechanisms for those in need in control communities, this ap-
proach also introduced questions about the extent of researcher’s
responsibilities to ensure continued access to beneficial interven-
tions beyond the short-term and after the conclusion of the trial.
What responsibilities do researchers have to ensure contin-
uation and uptake of effective interventions after the conclu-
sion of the trial? Although setting up a short-term response
mechanism allowed us to minimize the immediate harms experi-
enced by women in the control arm, we then had to make decisions
about how long to continue services for those in control areas, but
eventually for those in the intervention communities as well. The
question of posttrial access to effective interventions, or study
benefits more broadly, has been raised extensively in the context of
posttrial access to—HIV/AIDS drugs in particular (Doval, Shirali,
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& Sinha, 2015; Sugarman, Rose, & Metzger, 2014; Usharani, &
Naqvi, 2013)—and continues to present challenges with respect to
what interventions ought to be continued, for how long, and by
whom. Intervention evaluations similarly raise questions about
responsibility for sustainability of effective interventions and ex-
pansion to nontrial communities. In this low resource setting, it
was apparent that health systems’ constraints in terms of facilities
and human resources with expertise in IPV counseling were lim-
ited, and expansion would not be feasible without additional in-
vestment beyond what had been budgeted for in the evaluation.
Instead, the SHARE intervention aimed to engage community
members in all aspects of the project, including both participation
and implementation, and promote “community ownership” of pos-
itive change. For example, we trained CVs and counseling aides to
work as resident local SHARE ambassadors who would remain in
the study setting after the trial concluded. We took these steps to
increase local investment during the implementation of the inter-
vention and to increase its likelihood of sustainability after the
research and program funding ended. The last two years of the
intervention (Phase 5: 2008–2009) involved activities to transition
SHARE staff members away from routine work in the intervention
clusters and help community members assume the day-to-day
tasks of the project. Our objective was to help the community
develop long-term action plans and local bylaws that continued
prevention efforts, and ensured that they could sustain the reduced
levels of IPV and HIV transmission. Nonetheless, while SHARE
was associated with lower levels of IPV and HIV incidence during
the intervention period, multiple challenges including staff turn-
over and limited resources at local institutions hindered efforts to
sustain intervention activities in the community, and the reduction
in HIV transmission was not maintained after SHARE ended.
Thus, continued exposure to the full intervention might be needed
to achieve a sustained effect (Wagman, Gray, et al., 2015).
Lesson 3: Given Widespread Underreporting of IPV,
Evaluation of Violence Interventions May Have
Particularly High Levels of Unanticipated Demand
IPV is frequently underreported (Ellsberg & Heise, 2002; Wag-
man et al., 2008; World Health Organization, 2001), which may
exacerbate potential for complexities like those experienced in the
SHARE trial. At the same time, investing in evaluations of inter-
vention delivery methods, integration with existing programming,
and cost-effectiveness studies, is critically important for the
broader social value of preventing IPV and addressing underlying
risks for HIV infection and other adverse health outcomes. How-
ever, given the potentially high unmet need, crossover during
CRTs may be significant; “intention to treat” analyses will not be
sufficient to determine true intervention effects, nor will they
prepare researchers to respond to the ethical challenges of respond-
ing to unmet need. Thus, there is a need for additional guidance to
help researchers develop study designs that better address the
scientific and ethical challenges of evaluating IPV intervention
delivery approaches in low resource settings. In particular, addi-
tional guidance for developing short-term response and how to
eventually end such support will be needed for IPV intervention
research to progress in an ethical and effective way.
Conclusion
Given the global magnitude of IPV and its significant associa-
tions with a range of adverse outcomes, investments are needed to
find effective interventions for preventing IPV alone and in com-
bination with other outcomes, such as HIV transmission. The
practical and ethical complexities of conducting violence interven-
tion research, particularly when using a randomized trial design,
require further examination and discussion by researchers, practi-
tioners, interventionists, and those participating in the studies.
In their new guidelines, Hartmann and Krishnan (2014) set out
five recommendations regarding the safe and ethical conduct of
intervention research on VAW, two of which are particularly
relevant to the current paper: “Participant randomization should be
transparent and described in a way that can be easily understood by
those involved in the research” and “The provision of services to
comparison arm participants should maintain an ethically sound
standard of care.” Although these are important recommendations,
our experience indicates it will be necessary for researchers to
interpret them with respect to their own research setting and the
context in which the work is being conducted. Since specific
actions are often context-dependent, it may not be possible to
refine existing guidelines in a way that provides global standards
for conducting safe and ethical randomized IPV intervention trials.
However, with more empirical and normative work, we believe a
framework of relevant considerations could be developed to guide
violence intervention researchers through what are potentially
common challenges of randomized IPV research in low resource
settings. Such a framework could prompt researchers to systemat-
ically consider factors that may give rise to ethics concerns and
design their research in a way that better prepares them to respond
to unmet need in low resource settings and more fully develop
plans for transitioning short-term response activities to locally
sustainable practices. Sharing field lessons like those from the
SHARE intervention trial will be essential for developing this type
of framework, as well as revising and improving guidelines for the
ethical conduct of IPV intervention research in sub-Saharan Africa
and other settings.
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